Investors

News Release Details

Opiant Pharmaceuticals to Participate at the Jefferies 2020 Virtual London Healthcare Conference

November 2, 2020 at 4:01 PM EST

SANTA MONICA, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, announced today that its Chief Executive Officer, Dr. Roger Crystal, is scheduled to present its pipeline at the Jefferies 2020 Virtual London Healthcare Conference on Thursday, November 19th, 2020, at 6:45 pm GMT.

Management will be available for virtual one-on-one meetings throughout the conference taking place November 17-19, 2020. Please contact Jefferies sales representatives to participate in their investor conferences and to schedule a virtual one-on-one meeting with our management team. 

Investors, analysts, members of the media and the general public are invited to listen to an audio webcast of the presentation that can be accessed via the investor section of the Opiant website: www.opiant.com. A replay of the webcast will be available for 90 days following the event.

About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information, visit: www.opiant.com.

Investor Relations Contacts:

Ben Atkins
VP of Corporate Communications and Investor Relations
Batkins@opiant.com
(310) 598-5410


Opiant logo.jpg

Source: Opiant Pharmaceuticals, Inc.